Acute Pain, Breast Neoplasms, Erector Spinae Plane Block, Postoperative Pain, Serratus Posterior Superior Intercostal Plane Block
Conditions
Brief summary
Breast cancer is the most common malignancy in women. Modified radical mastectomy, a surgical procedure in the treatment of breast cancer, is one of the standard treatments. Postoperative pain can seriously reduce the quality of life in patients, and inadequately treated acute pain can trigger chronic pain syndrome. Therefore, thoracic paravertebral block and thoracic epidural block are effective in postoperative analgesia. However, the use of these blocks is limited due to complications. In recent years, less invasive blocks, such as pectoral nerve block (PECS I-II), Serratus anterior plane block (SAPB), Erector spinae plane block (ESPB), and Serratus Posterior Superior intercostal Plane Block (SPSİPB) have been applied. In this study, it was aimed to compare the analgesic effectiveness of ESPB and SPSİPB applications in patients undergoing breast surgery.
Detailed description
Postoperative pain will be assessed during resting and coughing with a visual analog scale (0-10 cm) and nausea and vomiting with a Postoperative Nausea Vomiting Score at the postoperative 1, 4, 8, 12, and 24 hours. The amount of tramadol consumed in the postoperative period will be recorded. Patient satisfaction will be assessed with the Likert scale at postoperative 24 hours.
Interventions
PROCEDUREErector Spinae Plane Block
Erector Spinae Plane Block will be performed unilaterally, under US guidance, before the surgical operation, when the patient is placed in the lateral decubitus position. 30 ml of 0.25% bupivacaine will be used in applications.
PROCEDURESerratus Posterior Superior Intercostal Plane Block
Serratus Posterior Superior Intercostal Plane Block will be performed unilaterally, under US guidance, before the surgical operation, when the patient is placed in the lateral decubitus position. 30 ml of 0.25% bupivacaine will be used in applications.
Sponsors
Diskapi Yildirim Beyazit Education and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Those aged 18-65 * Those with ASA scores I-II-III * Those with a body mass index (BMI) between 18-35 * Patients who will undergo breast surgery
Exclusion criteria
* Those under the age of 18 and over the age of 65 * Those with ASA score IV and above * Those with a history of allergy to the drugs to be blocked * Those with a history of bleeding diathesis * Patients with infection in the area to be blocked * Those with a BMI below 18 and above 35 * Patients who underwent surgery under emergency conditions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative analgesia | Postoperative day 1 | Pain will be assessed with a visual analog scale (0-10 cm) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative tramadol consumption | Perioperative day 1 | The amount of tramadol consumed in the postoperative period will be recorded |
| Patient satisfaction | Postoperative 24th hour | Satisfaction will be assessed with a 5 point Likert scale (0-4 whereas 0:definitely disagree; 1:slightly agree; 3: agree; 4: strongly agree) |
Countries
Turkey (Türkiye)
Outcome results
None listed